Bin Deng1, Fang Fang1, Tianlu Yang1, Zaixin Yu1, Bin Zhang2, Xiumei Xie3. 1. Department of Cardiology, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China. 2. Department of Histololgy and Embryololgy, Xiang Ya Medical College, Central South University 172 Tongzipo Road, Changsha 410013, Hunan, P. R. China. 3. Department of Geriatrics, Xiang Ya Hospital, Central South University 87 Xiang Ya Road, Changsha 410008, Hunan, P. R. China.
Abstract
AIM: Ghrelin, a gastric peptide, is involved in several metabolic and cardiovascular processes. Emerging evidence indicates the potential involvement of ghrelin in low-grade inflammatory diseases such as atherosclerosis and hypertension. Cytokine-induced inflammation is critical in these pathological states. The growth hormone secretagogue receptor (GHSR) has been identified in blood vessels, so we predict that ghrelin might inhibit proinflammatory responses in human umbilical vein endothelial cells (HUVECs). The aim of this study is to examine the effect of ghrelin on angiotension II (AngII)-induced expression of TNF-α, MCP-1, IL-8 in HUVECs. METHOD: HUVECs were pretreated with ghrelin, with or without the specific antagonist of GHSR [D-Lys(3)]-GHRP-6, the selective inhibitor of nuclear factor-kappaB (NF-κB) PDTC, and the selective inhibitor of extracellular signal-regulated kinase (ERK1/2) PD98059. The cells were finally treated with AngII. The expression of TNF-α, MCP-1, IL-8 was examined by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). The activity of ERK1/2 and NF-κB was analyzed by Western blot. RESULT: our study showed that ghrelin inhibited AngII -induced expression of IL-8, TNF-α and MCP-1 in the HUVECs via GHSR pathway in concentration- and time-dependent manners. We also found that ghrelin inhibited AngII -induced activation of ERK1/2 and NF-κB. CONCLUSIONS: these results suggest that Ghrelin may play novel antiinflammatory and immunoregulatory roles in HUVECs.
AIM: Ghrelin, a gastric peptide, is involved in several metabolic and cardiovascular processes. Emerging evidence indicates the potential involvement of ghrelin in low-grade inflammatory diseases such as atherosclerosis and hypertension. Cytokine-induced inflammation is critical in these pathological states. The growth hormone secretagogue receptor (GHSR) has been identified in blood vessels, so we predict that ghrelin might inhibit proinflammatory responses in human umbilical vein endothelial cells (HUVECs). The aim of this study is to examine the effect of ghrelin on angiotension II (AngII)-induced expression of TNF-α, MCP-1, IL-8 in HUVECs. METHOD: HUVECs were pretreated with ghrelin, with or without the specific antagonist of GHSR [D-Lys(3)]-GHRP-6, the selective inhibitor of nuclear factor-kappaB (NF-κB) PDTC, and the selective inhibitor of extracellular signal-regulated kinase (ERK1/2) PD98059. The cells were finally treated with AngII. The expression of TNF-α, MCP-1, IL-8 was examined by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). The activity of ERK1/2 and NF-κB was analyzed by Western blot. RESULT: our study showed that ghrelin inhibited AngII -induced expression of IL-8, TNF-α and MCP-1 in the HUVECs via GHSR pathway in concentration- and time-dependent manners. We also found that ghrelin inhibited AngII -induced activation of ERK1/2 and NF-κB. CONCLUSIONS: these results suggest that Ghrelin may play novel antiinflammatory and immunoregulatory roles in HUVECs.
Authors: V Sibilia; G Rindi; F Pagani; D Rapetti; V Locatelli; A Torsello; N Campanini; R Deghenghi; C Netti Journal: Endocrinology Date: 2003-01 Impact factor: 4.736
Authors: Krisztián Vörös; Zoltán Prohászka; Edit Kaszás; Anna Alliquander; András Terebesy; Ferenc Horváth; Leonard Janik; Agnes Sima; Judit Forrai; Károly Cseh; László Kalabay Journal: Arch Med Res Date: 2012-10-15 Impact factor: 2.235
Authors: Mohamed I Saad; Taha M Abdelkhalek; Moustafa M Saleh; Maher A Kamel; Mina Youssef; Shady H Tawfik; Helena Dominguez Journal: Endocrine Date: 2015-08-14 Impact factor: 3.633
Authors: Crina Claudia Rusu; Simona Racasan; Diana Moldovan; Alina Potra; Dacian Tirinescu; Cristian Budurea; Remus Orasan; Ioan Mihai Patiu; Cosmina Bondor; Dan Vladutiu; Dan Delean; Alexandra Danu; Ina Maria Kacso Journal: Int Urol Nephrol Date: 2018-07-13 Impact factor: 2.370
Authors: Marjan Nokhbehsaim; Anna Damanaki; Andressa Vilas Boas Nogueira; Sigrun Eick; Svenja Memmert; Xiaoyan Zhou; Shanika Nanayakkara; Werner Götz; Joni Augusto Cirelli; Andreas Jäger; James Deschner Journal: Mediators Inflamm Date: 2017-11-29 Impact factor: 4.711